FIR against five people filed by Maharashtra FDA for blackmarketing of remedisivir and tocilizumab

The Maharashtra Food and Drug Administration (FDA), along with Anti Extortion Cell (AEC), has filed the FIR for black marketing racket of remdisivir and tocilizumab drugs. The team also seized other therapeutic medicines worth Rs 3,13,482.

Viraj Paunikar, Joint Commissioner, Thane FDA, informed, “Two days back, an activist informed the Thane, Mumbai police about the black marketing of COVID-19 drugs within the vicinity. Based on the information, we put up a trap and arrested five people involved in selling Cipla’s cipremi (remdesivir) and actemra (tocilizumab) without a drug sale license; and we caught them red-handed selling remdesivir at Rs 25,000 (the company’s MRP of the said drug is Rs 4,000) and tocilizumab approximately at Rs 80,000, which are much higher than the market retail prices. All five of them are found guilty in violating different sections of the Indian Penal Code (IPC) like section 420, 34, etc., along with DPCO, essential commodities Act, Drugs and Cosmetic Rules/Act, etc. Hence, the local police have filed the first information report (FIR) against them,” informed Paunikar.

“From the initial investigation, the team realised that the master mind of this racket was Amitabh Das, a resident of Kalamboli, Raigad district. From his house, we have collected other medicines like anti-cancer drug, MTP kits, etc; and the team is investigating about the source of these medicines.” He further added
Jugalkishor B Mantri, Joint Commissioner, State Controller, Maharashtra and State Drug Controlling Authority of Mumbai, said that, “Together, local police administration and state FDA officers are working aggressively to bring down the unethical marketing practices in the state.”

“To address the issues related to the unavailability as well as black marketing of essential drugs in the state, we have recently launched the 24×7 control room at our Mumbai head office, and infact, we have got a lead of another black marketing of these medicines (remdesivir and tocilizumab) and we are working on that lead and hopefully in few days will be able to spot that racket too.” He further added.

  • Related Posts

    • Health
    • June 11, 2025
    • 296 views
    Doctors trialling ‘poo pills’ to flush out dangerous superbugs

    UK doctors are attempting to clear dangerous superbug infections using “poo pills” containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data…

    • Health
    • May 26, 2025
    • 200 views
    Three Day IGHM fame Healthcare Conclave proved Mahakumbh of Who’s Who

    Integrated Global Healthcare Mission Forum (IGHM) honored domain’s Champions of Humanity New Delhi: It was a veritable Mahakumbh of Who’s Who of healthcare’s varied aspects namely Hospitals, Medtech, Pharmacy, Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations